Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000890163-06-000778
Filing Date
2006-11-29
Accepted
2006-11-29 10:12:03
Documents
1
Period of Report
2006-10-31

Document Format Files

Seq Description Document Type Size
1 s11-6857d_ex.html 3  
1 s11-6857d_ex.xml 3 3601
  Complete submission text file 0000890163-06-000778.txt   5398
Mailing Address 1220 GLENMORE DRIVE APOPKA FL 32712
Business Address 1220 GLENMORE DRIVE APOPKA FL 32712 407-880-2213
SHEFFIELD PHARMACEUTICALS INC (Issuer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address
Business Address 150 RBROADWAY SUITE 1100 NEW YORK NY 10038
RUDICK A JOSEPH (Reporting) CIK: 0001076654 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12584 | Film No.: 061243853